Discordant assessment of lupus activity between patients and their physicians: The Singapore experience

Lupus

Volumn 19, Issue 1, 2010, Pages 100-106

  Leong, K P ^a   Chong, E Y Y ^a,b   Kong, K O ^a   Chan, S P ^c   Thong, B Y H ^a   Lian, T Y ^a   Chng, H H ^a   Koh, E T ^a   Teh, C L ^a,d   Lau, T C ^a   Law, W G ^a   Cheng, Y K ^a,e   Badsha, H ^a,f   Chew, L C ^a,g   Yong, W H ^a   Howe, H S ^a  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b Division of Medicine Hospital Selayang   (Malaysia)

^c Singapore Institute of Management   (Singapore)

^d SARAWAK GENERAL HOSPITAL   (Malaysia)

^e GLENEAGLES HOSPITAL   (Singapore)

^f Dubai Bone and Joint Center   (United Arab Emirates)

^g SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Activity index; Quality of life; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; FATIGUE; FEMALE; HEMOLYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT ASSESSMENT; PHOTOSENSITIVITY; PHYSICIAN; PRIORITY JOURNAL; PROTEINURIA; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; SINGAPORE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; URINE SEDIMENT;

ADULT; FEMALE; HUMANS; LINEAR MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SINGAPORE;

EID: 74849112458     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309345748     Document Type: Article

References (27)

1. Barr SG, Zonana-Nacach A., Magder LS, Petri M. Patterns of disease activity in systemic lupus erythematosus. Arthritis Rheum 1999 ; 42: 2682-2688.
2. Petri M., Buyon J., Kim M. Classification and definition of major flares in SLE clinical trials. Lupus 1999 ; 8: 685-691.
3. Fortin PR, Abrahamowicz M., Danoff D. Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory tests. J Rheumatol 1995 ; 22: 2078-2083.
4. Wollaston SJ, Farewell VT, Isenberg DA, et al. Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics Group. J Rheumatol 2004 ; 31: 2390-2394.
5. Yen JC, Neville C., Fortin PR Discordance between patients and their physicians in the assessment of lupus disease activity: relevance for clinical trials. Lupus 1999 ; 8: 660-670.
6. Leong KP, Pong LY, Chan SP Why lupus patients use alternative medicine. Lupus 2003 ; 12: 659-664.
7. AlarcÓn GS, McGwin G.Jr, Brooks K., et al. Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores. Arthritis Rheum 2002 ; 47: 408-413.
8. Yen JC, Abrahamowicz, Dobkin PL, Clarke AE, Battista RN, Fortin PR Determinants of discordance between patients and physicians in their assessment of lupus disease activity. J Rheumatol 2003 ; 30: 1967-1976.
9. Neville C., Clarke AE, Joseph L., Belisle P., Ferland D., Fortin PR Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 2000 ; 27: 675-679.
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 ; 25: 1271-1277.
11. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 1725.
12. Leong KP, Kong KO, Thong B., et al. Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology 2005 ; 44: 1267-1276.
13. Bombardier C., Gladman DD, Urowitz MB, Caron D., Chang CH Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992 ; 35: 630-640.
14. Liang MH, Socher SA, Larson MG, Schur PH Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989 ; 32: 1107-1118.
15. Nicassio PM, Wallston KA, Callahan LF, Herbert M., Pincus T. The measurement of helplessness in rheumatoid arthritis. The development of the Arthritis Helplessness Index. J Rheumatol 1985 ; 12: 462-467.
16. Ware JE, Sherbourne CD The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 ; 30: 473-483.
17. McHorney CA, Ware JE, Raczek AE The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1992 ; 31: 247-263.
18. McHorney CA, Ware JE, Lu RJF, Sherbourne CD The MOS 36-Item Short-Form Health Survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994 ; 32: 40-66.
19. Stoll T., Seifert B., Isenberg DA SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996 ; 35: 248-254.
20. Gladman DD, Ginzler E., Goldsmith C., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996 ; 39: 363-369.
21. Engle EW, Callahan LF, Pincus T., Hochberg MC Learned helplessness in systemic lupus erythematosus: analysis using the Rheumatology Attitudes Index. Arthritis Rheum 1990 ; 33: 281-286.
22. Carr AJ, Donovan JL Why doctors and patients disagree. Br J Rheumatol 1998 ; 37: 1-6.
23. Potter T., Wild A., Edwards K., Rai A., Rowe IF Patients own ability to assess activity of their rheumatoid arthritis (letter). Rheumatology 2006 ; 45: 1044.
24. Liang MH, Soucher SA, Larson MG, Schur PH Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989 ; 32: 1107-1118.
25. Morand EF, Miller MH, Whittingham S., Littlejohn GO Fibromyalgia and disease activity in systemic lupus erythematosus. Lupus 1994 ; 3: 187-191.
26. Fortin PR, Abrahamowicz M., Neville C., et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus 1998 ; 7: 101-107.
27. Chang ER, Abrahamowicz M., Ferland D., Fortin PR Organ manifestations influence differently the responsiveness of 2 lupus disease activity measures, according to patients or physicians evaluations of recent lupus activity. J Rheumatol 2002 ; 29: 2350-2358.